| Trial ID: | L0412 |
| Source ID: | ChiCTR2000038111
|
| Associated Drug: |
Danggui Shaoyao Powder
|
| Title: |
Study for effect of Danggui Shaoyao Powder in the treatment of Non-alcoholic Fatty Liver Disease
|
| Acronym: |
--
|
| Status: |
Not Recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic fatty liver disease
|
| Interventions: |
Experimental group:Danggui Shaoyao Powder;Control group:Danggui Shaoyao Powder Placebo;
|
| Outcome Measures: |
MRI-PDFF;serum activity of ALT; liver stiffness measurements;weight;BMI;waistline;serum levels of TC;serum levels of TG;serum levels of LDL;serum levels of HDL-C;fasting blood-glucose;fasting insulin;insulin resistance index;SF-36;CLDQ NAFLD;
|
| Sponsor/Collaborators: |
Shuguang Hospital affiliated to Shanghai University of TCM
|
| Gender: |
All
|
| Age: |
1865
|
| Phases: |
Not applicable
|
| Enrollment: |
Experimental group:84;Control group:84;
|
| Study Type: |
Interventional study
|
| Study Designs: |
Parallel
|
| Start Date: |
11/09/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
24 November 2020
|
| Locations: |
China
|
| URL: |
http://www.chictr.org.cn/showproj.aspx?proj=61305
|
